Leqembi IQLIK, a subcutaneous version of Leqembi, will launch on Oct. 6, 2025, with a list price of $375 per autoinjector.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

COVID-19 reveals significant political polarization in public health, impacting vaccine attitudes and infection concerns among Democrats and Republicans.

Real-world treatment of patients with advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) is marked by high drug costs and relatively short treatment durations, ...

In a study published in Aging on Aug. 8, 2025, researchers at Insilico Medicine unveiled AI-powered models that uncover shared biological pathways between IPF and the aging process, pointing to novel ...

Bildyos and Bilprevda have the same indications as the reference products Prolia and Xgeva and are expected to be available later this year.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

In separate announcements, Form Health and 9amHealth said they would provide patients seeking support for obesity care with ...

Researchers suggest that access to treatment and socioeconomic resources can influence glycemic control and disparities in the management of patients with Type 1 diabetes.

With healthcare costs climbing, Stuart will lead the nonprofit insurer’s push to keep coverage affordable for 6 million ...

Researchers from the University of Michigan have developed a skin patch that was able to accurately detect melanoma in tissue ...

The FDA suspends Ixchiq, the only approved chikungunya vaccine, over safety concerns, impacting its availability in the U.S.